NEK1 variants confer susceptibility to amyotrophic lateral sclerosis
In a clinical pilot study, diazoxide was used at a relatively low dose of 200300 mg/day
Tirzepatide, Mounjaro, is already a primary type 2 diabetes medication, but could also work as an adjunct treatment, according to new research
A 2025 study in the American Journal of Ophthalmology did not find a significant increase in NAION or ischemic optic neuropathy risk in patients taking semaglutide or GLP-1 medications compared with diabetes or high-BMI control groups
The Centers for Disease Control and Prevention (CDC) states that if a multi-dose vial has been opened or accessed (e.g., needle-punctured) the vial should be dated and discarded within 28 days unless the manufacturer specifies a different (shorter or longer) date for that opened vial
The US held the largest share of the GLP-1 analogues market in North America in 2024